Aclaris Therapeutics (ACRS) Gross Margin (2017 - 2026)
Aclaris Therapeutics' Gross Margin was 86.62% in Q2 2026, up 15.60 percentage points from 71.02% a year earlier and up 6.41 percentage points from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Gross Margin (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Aclaris Therapeutics' Gross Margin was 79.52% through Jun 30, 2026, down 6.30 percentage points year-over-year; for FY2025, it was 73.28%, down 11.80 percentage points from FY2024.
- Gross Margin shows a five-year change of +52.47 percentage points (FY2020 to FY2025).
- In earlier years, Gross Margin was 85.09% in FY2024 (-3.96 pp), 89.05% in FY2023 (+2.57 pp), 86.48% in FY2022 (+56.19 pp) and 30.29% in FY2021 (+9.48 pp).
- The Q2 2026 figure marks the highest quarterly Gross Margin since Q4 2024.
- Compared with a year earlier, Gross Margin was higher in two of the last eight quarters, with an average year-over-year change of -2.63 percentage points.
- The best year-over-year quarter for Gross Margin over five years was Q4 2022 (a gain of 65.24 percentage points); the worst was Q4 2025 (a drop of 33.43 percentage points).
- Per Business Quant data, ACRS's Gross Margin in the three quarters before Q2 2026 was 80.21% (Q1 2026), 58.92% (Q4 2025) and 83.69% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Aclaris Therapeutics | 759.25 Mn | 759.25 Mn | 1.41 Mn | 86.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 86.62% |
| Mar 31, 2026 | 80.21% |
| Dec 31, 2025 | 58.92% |
| Sep 30, 2025 | 83.69% |
| Jun 30, 2025 | 71.02% |
| Mar 31, 2025 | 65.22% |
| Dec 31, 2024 | 92.35% |
| Sep 30, 2024 | 84.95% |
| Jun 30, 2024 | 77.44% |
| Mar 31, 2024 | 66.26% |
| Dec 31, 2023 | 95.87% |
| Sep 30, 2023 | 90.86% |
| Jun 30, 2023 | 44.25% |
| Mar 31, 2023 | 68.04% |
| Dec 31, 2022 | 88.69% |
| Sep 30, 2022 | 95.15% |
| Jun 30, 2022 | 30.10% |
| Mar 31, 2022 | 20.51% |
| Dec 31, 2021 | 23.45% |
| Sep 30, 2021 | 33.76% |
API Access
Aclaris Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();